Report cover image

Global Oral Vaccines Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 198 Pages
SKU # APRC20280359

Description

Summary

According to APO Research, the global Oral Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Oral Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Oral Vaccines market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Oral Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Oral Vaccines market include Bibcol, Bio-Med, EuBiologics, Halfkin Bio-Pharmaceuticals, Panacea Biotec Ltd, PaxVax, Serum Institute, Tiantan Biological and Vabiotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Oral Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Oral Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Oral Vaccines sales, projected growth trends, production technology, application and end-user industry.

Oral Vaccines Segment by Company

Bibcol
Bio-Med
EuBiologics
Halfkin Bio-Pharmaceuticals
Panacea Biotec Ltd
PaxVax
Serum Institute
Tiantan Biological
Vabiotech
Valneva
GSK
Lanzhou Institute
Merck
Sanofi
Shanghai United Cell
Oral Vaccines Segment by Type

Rotavirus Vaccine
Oral Polio Vaccine
Cholera Vaccine
Oral Vaccines Segment by Application

Public
Private
Oral Vaccines Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Oral Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Oral Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Oral Vaccines significant trends, drivers, influence factors in global and regions.
6. To analyze Oral Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Vaccines industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Oral Vaccines in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Vaccines Sales Value (2020-2031)
1.2.2 Global Oral Vaccines Sales Volume (2020-2031)
1.2.3 Global Oral Vaccines Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Oral Vaccines Market Dynamics
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 Oral Vaccines Market by Company
3.1 Global Oral Vaccines Company Revenue Ranking in 2024
3.2 Global Oral Vaccines Revenue by Company (2020-2025)
3.3 Global Oral Vaccines Sales Volume by Company (2020-2025)
3.4 Global Oral Vaccines Average Price by Company (2020-2025)
3.5 Global Oral Vaccines Company Ranking (2023-2025)
3.6 Global Oral Vaccines Company Manufacturing Base and Headquarters
3.7 Global Oral Vaccines Company Product Type and Application
3.8 Global Oral Vaccines Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Oral Vaccines Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Oral Vaccines Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Oral Vaccines Market by Type
4.1 Oral Vaccines Type Introduction
4.1.1 Rotavirus Vaccine
4.1.2 Oral Polio Vaccine
4.1.3 Cholera Vaccine
4.2 Global Oral Vaccines Sales Volume by Type
4.2.1 Global Oral Vaccines Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Oral Vaccines Sales Volume by Type (2020-2031)
4.2.3 Global Oral Vaccines Sales Volume Share by Type (2020-2031)
4.3 Global Oral Vaccines Sales Value by Type
4.3.1 Global Oral Vaccines Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Oral Vaccines Sales Value by Type (2020-2031)
4.3.3 Global Oral Vaccines Sales Value Share by Type (2020-2031)
5 Oral Vaccines Market by Application
5.1 Oral Vaccines Application Introduction
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Sales Volume by Application
5.2.1 Global Oral Vaccines Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Oral Vaccines Sales Volume by Application (2020-2031)
5.2.3 Global Oral Vaccines Sales Volume Share by Application (2020-2031)
5.3 Global Oral Vaccines Sales Value by Application
5.3.1 Global Oral Vaccines Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Oral Vaccines Sales Value by Application (2020-2031)
5.3.3 Global Oral Vaccines Sales Value Share by Application (2020-2031)
6 Oral Vaccines Regional Sales and Value Analysis
6.1 Global Oral Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Oral Vaccines Sales by Region (2020-2031)
6.2.1 Global Oral Vaccines Sales by Region: 2020-2025
6.2.2 Global Oral Vaccines Sales by Region (2026-2031)
6.3 Global Oral Vaccines Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Oral Vaccines Sales Value by Region (2020-2031)
6.4.1 Global Oral Vaccines Sales Value by Region: 2020-2025
6.4.2 Global Oral Vaccines Sales Value by Region (2026-2031)
6.5 Global Oral Vaccines Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Oral Vaccines Sales Value (2020-2031)
6.6.2 North America Oral Vaccines Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Oral Vaccines Sales Value (2020-2031)
6.7.2 Europe Oral Vaccines Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Oral Vaccines Sales Value (2020-2031)
6.8.2 Asia-Pacific Oral Vaccines Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Oral Vaccines Sales Value (2020-2031)
6.9.2 South America Oral Vaccines Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Oral Vaccines Sales Value (2020-2031)
6.10.2 Middle East & Africa Oral Vaccines Sales Value Share by Country, 2024 VS 2031
7 Oral Vaccines Country-level Sales and Value Analysis
7.1 Global Oral Vaccines Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Oral Vaccines Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Oral Vaccines Sales by Country (2020-2031)
7.3.1 Global Oral Vaccines Sales by Country (2020-2025)
7.3.2 Global Oral Vaccines Sales by Country (2026-2031)
7.4 Global Oral Vaccines Sales Value by Country (2020-2031)
7.4.1 Global Oral Vaccines Sales Value by Country (2020-2025)
7.4.2 Global Oral Vaccines Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Oral Vaccines Sales Value Growth Rate (2020-2031)
7.5.2 USA Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Oral Vaccines Sales Value Growth Rate (2020-2031)
7.6.2 Canada Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Oral Vaccines Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Oral Vaccines Sales Value Growth Rate (2020-2031)
7.8.2 Germany Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Oral Vaccines Sales Value Growth Rate (2020-2031)
7.9.2 France Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.9.3 France Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Oral Vaccines Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Oral Vaccines Sales Value Growth Rate (2020-2031)
7.11.2 Italy Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Oral Vaccines Sales Value Growth Rate (2020-2031)
7.12.2 Spain Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Oral Vaccines Sales Value Growth Rate (2020-2031)
7.13.2 Russia Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Oral Vaccines Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Oral Vaccines Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Oral Vaccines Sales Value Growth Rate (2020-2031)
7.16.2 China Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.16.3 China Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Oral Vaccines Sales Value Growth Rate (2020-2031)
7.17.2 Japan Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Oral Vaccines Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Oral Vaccines Sales Value Growth Rate (2020-2031)
7.19.2 India Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.19.3 India Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Oral Vaccines Sales Value Growth Rate (2020-2031)
7.20.2 Australia Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Oral Vaccines Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Oral Vaccines Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Oral Vaccines Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Oral Vaccines Sales Value Growth Rate (2020-2031)
7.24.2 Chile Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Oral Vaccines Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Oral Vaccines Sales Value Growth Rate (2020-2031)
7.26.2 Peru Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Oral Vaccines Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Oral Vaccines Sales Value Growth Rate (2020-2031)
7.28.2 Israel Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Oral Vaccines Sales Value Growth Rate (2020-2031)
7.29.2 UAE Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Oral Vaccines Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Oral Vaccines Sales Value Growth Rate (2020-2031)
7.31.2 Iran Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Oral Vaccines Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Oral Vaccines Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Oral Vaccines Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Oral Vaccines Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Bibcol
8.1.1 Bibcol Comapny Information
8.1.2 Bibcol Business Overview
8.1.3 Bibcol Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.1.4 Bibcol Oral Vaccines Product Portfolio
8.1.5 Bibcol Recent Developments
8.2 Bio-Med
8.2.1 Bio-Med Comapny Information
8.2.2 Bio-Med Business Overview
8.2.3 Bio-Med Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.2.4 Bio-Med Oral Vaccines Product Portfolio
8.2.5 Bio-Med Recent Developments
8.3 EuBiologics
8.3.1 EuBiologics Comapny Information
8.3.2 EuBiologics Business Overview
8.3.3 EuBiologics Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.3.4 EuBiologics Oral Vaccines Product Portfolio
8.3.5 EuBiologics Recent Developments
8.4 Halfkin Bio-Pharmaceuticals
8.4.1 Halfkin Bio-Pharmaceuticals Comapny Information
8.4.2 Halfkin Bio-Pharmaceuticals Business Overview
8.4.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.4.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
8.4.5 Halfkin Bio-Pharmaceuticals Recent Developments
8.5 Panacea Biotec Ltd
8.5.1 Panacea Biotec Ltd Comapny Information
8.5.2 Panacea Biotec Ltd Business Overview
8.5.3 Panacea Biotec Ltd Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.5.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
8.5.5 Panacea Biotec Ltd Recent Developments
8.6 PaxVax
8.6.1 PaxVax Comapny Information
8.6.2 PaxVax Business Overview
8.6.3 PaxVax Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.6.4 PaxVax Oral Vaccines Product Portfolio
8.6.5 PaxVax Recent Developments
8.7 Serum Institute
8.7.1 Serum Institute Comapny Information
8.7.2 Serum Institute Business Overview
8.7.3 Serum Institute Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.7.4 Serum Institute Oral Vaccines Product Portfolio
8.7.5 Serum Institute Recent Developments
8.8 Tiantan Biological
8.8.1 Tiantan Biological Comapny Information
8.8.2 Tiantan Biological Business Overview
8.8.3 Tiantan Biological Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.8.4 Tiantan Biological Oral Vaccines Product Portfolio
8.8.5 Tiantan Biological Recent Developments
8.9 Vabiotech
8.9.1 Vabiotech Comapny Information
8.9.2 Vabiotech Business Overview
8.9.3 Vabiotech Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.9.4 Vabiotech Oral Vaccines Product Portfolio
8.9.5 Vabiotech Recent Developments
8.10 Valneva
8.10.1 Valneva Comapny Information
8.10.2 Valneva Business Overview
8.10.3 Valneva Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.10.4 Valneva Oral Vaccines Product Portfolio
8.10.5 Valneva Recent Developments
8.11 GSK
8.11.1 GSK Comapny Information
8.11.2 GSK Business Overview
8.11.3 GSK Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.11.4 GSK Oral Vaccines Product Portfolio
8.11.5 GSK Recent Developments
8.12 Lanzhou Institute
8.12.1 Lanzhou Institute Comapny Information
8.12.2 Lanzhou Institute Business Overview
8.12.3 Lanzhou Institute Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.12.4 Lanzhou Institute Oral Vaccines Product Portfolio
8.12.5 Lanzhou Institute Recent Developments
8.13 Merck
8.13.1 Merck Comapny Information
8.13.2 Merck Business Overview
8.13.3 Merck Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.13.4 Merck Oral Vaccines Product Portfolio
8.13.5 Merck Recent Developments
8.14 Sanofi
8.14.1 Sanofi Comapny Information
8.14.2 Sanofi Business Overview
8.14.3 Sanofi Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.14.4 Sanofi Oral Vaccines Product Portfolio
8.14.5 Sanofi Recent Developments
8.15 Shanghai United Cell
8.15.1 Shanghai United Cell Comapny Information
8.15.2 Shanghai United Cell Business Overview
8.15.3 Shanghai United Cell Oral Vaccines Sales, Value and Gross Margin (2020-2025)
8.15.4 Shanghai United Cell Oral Vaccines Product Portfolio
8.15.5 Shanghai United Cell Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Oral Vaccines Value Chain Analysis
9.1.1 Oral Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Oral Vaccines Sales Mode & Process
9.2 Oral Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Oral Vaccines Distributors
9.2.3 Oral Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.